Investigating the effects of community interventions to improve youth mental health

ISRCTN ISRCTN10661245
DOI https://doi.org/10.1186/ISRCTN10661245
Submission date
12/03/2025
Registration date
23/04/2025
Last edited
29/05/2025
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
The study addresses youth mental health among emerging adults. Through an interventional study in five countries, the research aims to provide data on youth mental health and on the effects of community interventions for improving youth mental health.

Who can participate?
People aged 15-24 years old

What does the study involve?
The study involves community interventions and online mental health training.

What are the possible benefits and risks of participating?
The benefits of participating are better mental health. No risks are anticipated.

Where is the study run from?
The study is run by the University of Applied Sciences Emden-Leer in five countries (Belgium, Germany, Moldova, Poland, and Portugal).

When is the study starting and how long is it expected to run for?
January 2024 to April 2026.

Who is funding the study?
The study is funded by the European Commission under the Horizon 2020 program.

Who is the main contact?
Prof Dr. Jutta Lindert, jutta.lindert@hs-emden-leer.de

Contact information

Prof Jutta Lindert
Public, Scientific, Principal Investigator

University of Applied Sciences Emden-Leer, Constantiaplatz 4
Emden
26723
Germany

ORCiD logoORCID ID 0000-0001-5368-3886
Phone +491774158919
Email Jutta.Lindert@hs-emden-leer.de

Study information

Study designMulti-center community unblinded interventional study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Community, Internet/virtual
Study typeOther, Prevention
Participant information sheet Not available in web format, please use contact details to request a participant information sheet.
Scientific titleInvestigating the effects of community interventions to improve youth mental health in comparison with youth mental health without community interventions
Study acronymEARLY
Study objectivesCommunity interventions improve the mental health of people aged 15-24 years old more than no interventions.
Ethics approval(s)

Approved 27/01/2024, Institutional Review Board University of Emden / Leer (Constantiaplatz 4, Emden, 26723, Germany; +49 4921/807-1007 ; vp.forschung-transfer@hs-emden-leer.de), ref: 2024_EARLY_03

Health condition(s) or problem(s) studiedPromotion of mental health and prevention of depression and anxiety.
InterventionThe study is a multi-center community unblinded interventional study. Two communities will be identified in five countries, purposively (allocation of intervention is purposively). These are the intervention communities. The two intervention communities will be matched by age distribution, gender distribution and density with two other communities. These are the control communities. Communities will not be masked.

In the intervention communities, key person groups, parent groups, and youth groups will be gathered three times. Information about relationships and their impact on mental health will be disseminated in these groups. Additionally, in the intervention communities opportunities to participate in a short mental health promotion online course will be disseminated. In the control communities, no groups are formed.
Intervention typeBehavioural
Primary outcome measureCurrent primary outcome measure as of 29/05/2025:

Resilience is measured using the Child Youth Resilience Measure (CYRM-R), Executive Functioning is measured using the Adult Executive Function Inventory (ADEXI), and Emotional regulation is measured using the Emotion Regulation Questionnaire (ERQ) at baseline (T1), mid-intervention (T2), end of intervention (T3), and (T0) follow-up

_____

Previous primary outcome measure:

Mental health is measured using the Brief Resilience Scale (BRS) at baseline (T1), mid-intervention (T2), end of intervention (T3), and (T0) follow-up


Secondary outcome measuresCurrent secondary outcome measures as of 29/05/2025:

The following secondary outcome measures are assessed at baseline (T0), mid-intervention (T1), end of intervention (T2), and follow-up (T3):
1. Depression measured using the Patient Health Questionnaire-9 (PHQ-9)
2. Anxiety measured using the Generalized Anxiety Disorder-7 (GAD-7)
3. Stress disorder measured using the International Trauma Questionnaire (ITQ)
4. Substance use measured using the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST – LITE)
5. Gratitude measured using the The Gratitude Questionnaire-6, (GQ-6)
6. Optimism measured using the Revised Life Orientation Test (LOT-R)
7. Well-being measured using the Wellbeing Scale

_____

Previous secondary outcome measures:

The following secondary outcome measures are assessed at baseline (T0), mid-intervention (T1), end of intervention (T2), and follow-up (T3):
1. Depression measured using the Patient Health Questionnaire-9  for teens (PHQ-A)
2. Anxiety measured using the Generalized Anxiety Disorder-7  (GAD-7)
3. Stress disorder measured using the International Trauma Questionnaire (ITQ)
4. Substance use measured using the International Trauma Questionnaire (ITQ) and the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST – LITE)
5. Executive functioning measured using the Teenage/Adult Executive Function Inventory
6. Emotional control measured using the Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA)
7. Resilience measured using the Child Youth Resilience Measure (CYRM-R)
8. Gratitude measured using the The Gratitude Questionnaire-6, (GQ-6)
9. Optimism measured using the Revised Life Orientation Test (LOT-R)
10. Well-being measured using the Wellbeing Scale
Overall study start date27/01/2024
Completion date15/04/2026

Eligibility

Participant type(s)Service user
Age groupMixed
Lower age limit15 Years
Upper age limit24 Years
SexBoth
Target number of participants15000
Total final enrolment12000
Key inclusion criteria1. Aged 15-24 years old
2. Proficient in the national language
3. Informed consent
Key exclusion criteriaNot meeting the participant inclusion criteria
Date of first enrolment15/04/2025
Date of final enrolment15/07/2025

Locations

Countries of recruitment

  • Belgium
  • Germany
  • Moldova
  • Poland
  • Portugal

Study participating centres

University of Applied Sciences Emden / Leer
Constantiaplatz 4
Emden
26423
Germany
Hopital Universitaire de Bruxelles
Av. Franklin Roosevelt 50
Bruxelles
1050
Belgium
Society of psychiatrists, narcologists, psychotherapists and clinical psychologists from Moldova
Str. Columna 130
Chisenau
MD 2001
Moldova
Gdansk University
Jana Baszynskiego 8
Gdansk
80-309
Poland

Sponsor information

Directorate-General Joint Research Centre
Government

European Commission, Rue de la Loi
Brussels
1040
Belgium

Phone +3222991111
Email webmaster@ec.europa.eu
Website http://ec.europa.eu/index_en.htm
ROR logo "ROR" https://ror.org/04j5wtv36

Funders

Funder type

Government

Horizon 2020 Framework Programme
Government organisation / National government
Alternative name(s)
EU Framework Programme for Research and Innovation H2020, Horizon 2020, Rahmenprogramm Horizont 2020, Programa Marco Horizonte 2020, Programme-cadre Horizon 2020, Programma quadro Orizzonte 2020, Program ramowy Horyzont 2020, Horizont 2020, Horizonte 2020, Orizzonte 2020, Horyzont 2020, Horizon 2020 Framework Programme (H2020), H2020

Results and Publications

Intention to publish date15/01/2027
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publications in peer-reviewed journals.
IPD sharing planThe datasets generated during the current study will be available upon request from Prof. Dr. Jutta Lindert (jutta.lindert@hs-emden-leer.de).
• The type of data that will be shared: raw data
• Timing for availability: July 2028
• Whether consent from participants was required and obtained: yes, informed consent will be obtained
• Comments on data anonymization: data are anonymized in line with the European data regulation laws.
• Any ethical or legal restrictions. Data transfer in line with the legal restrictions of European regulations.
• Any additional comments. No

Editorial Notes

29/05/2025: The following changes were made to the trial record:
1. The primary outcome measure was changed.
2. The secondary outcome measures were changed.
17/03/2025: Study's existence confirmed by the Institutional Review Board University of Emden / Leer.